Skip to main content

Security report for amicusassisthcp.com

Amicus Therapeutics, Inc. · Healthcare · United States

Medium risk. 5 critical or high findings in Email security, Security headers and 1 other check.

Security score

67/100

Risk levelMedium

0–100, higher is better. How it is calculated

AmicusAssistHCP.com is a dedicated patient support website operated by Amicus Therapeutics, Inc., targeting US healthcare professionals who prescribe Amicus medications. The site provides resources, referral forms, and direct phone support to assist patients with insurance, financial aid, and treatment coordination. The business model focuses on enhancing patient adherence and support through personalized assistance, positioning Amicus Therapeutics as a patient-centric pharmaceutical company. Technically, the website employs modern web technologies including Bootstrap, jQuery, Google Tag Manager, and OneTrust for cookie consent, hosted via GoDaddy. The site is mobile-optimized and accessible, with a moderate performance profile. Security posture is adequate with HTTPS and cookie consent mechanisms, though security headers and DNSSEC are not enabled, representing areas for improvement. Privacy compliance is strong, with clear links to comprehensive privacy and terms of use hosted on the parent company domain. Overall, the website is professional, trustworthy, and aligned with healthcare industry standards.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching amicusassisthcp.com

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
25
Email security
40
DNS health
75
Network security
100
GDPR outside view
88
Average
67

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website serves as a specialized support portal for Amicus Therapeutics' pharmaceutical products, focusing on Fabry and Late-Onset Pompe Disease (LOPD) patients. It leverages partnerships with related domains for patient engagement and legal compliance. The business benefits from clear market positioning as a healthcare support service, with a medium-sized organizational footprint and a recent domain registration consistent with a new program launch. The absence of direct email contacts but presence of dedicated phone lines indicates a controlled communication channel. The site’s content and navigation are tailored to healthcare professionals, enhancing user experience and trust. The partnership ecosystem includes related Amicus domains and disease-specific support sites, reinforcing the company’s integrated patient support strategy.

Security posture

The website demonstrates a baseline security posture with HTTPS enforced and a cookie consent mechanism compliant with GDPR. However, it lacks explicit security headers such as Content Security Policy, HSTS, and X-Frame-Options, which are recommended to mitigate common web vulnerabilities. DNSSEC is not enabled, which could improve domain name system security. No incident response or security contact information is published, limiting transparency in security governance. The use of third-party scripts like Google Tag Manager and OneTrust is standard but requires ongoing monitoring for vulnerabilities. No exposed sensitive data or vulnerable libraries were detected in the HTML content. Overall, the security maturity is moderate, suitable for a healthcare support site but with room for enhancement.

Recommendations

  1. Implement comprehensive HTTP security headers including CSP, HSTS, and X-Frame-Options.
  2. Enable DNSSEC for the domain to enhance DNS security.
  3. Publish a dedicated security policy and incident response contact information.
  4. Regularly audit and update third-party scripts to mitigate supply chain risks.
  5. Enhance SEO optimization with meta tags and structured data for better discoverability.

Contact details published on the site

Addresses
Legal name
Amicus Therapeutics, Inc.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Amicus Therapeutics, Inc.
Description
AMICUS ASSIST® is a program that provides dedicated support to individuals who have been prescribed an Amicus medication, helping with insurance, financial assistance, and ongoing treatment support.
Key services
Insurance coverage verification, Prior authorization assistance, Prescription delivery coordination, Financial assistance identification, Ongoing treatment support, Spanish-speaking case manager connection
Content quality
good
Branding
consistent

Technology

Stack
Bootstrap, jQuery, Google Tag Manager, OneTrust Cookie Consent, AOS (Animate On Scroll), Font Awesome, Google Fonts, ACSB Accessibility JS
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
good
SEO
basic

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced (implied by domain and scripts)
  • Cookie consent banner implemented
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
OneTrust Cookie Consent
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is targeted exclusively at US healthcare professionals.
  2. Strong emphasis on patient support for Amicus Therapeutics medications.
  3. Comprehensive cookie consent and privacy mechanisms implemented.
  4. No forms collecting personal data detected on main pages.
  5. No email addresses found; contact is via phone only.
  6. Multiple modals warn users about leaving the site, indicating careful user flow control.
  7. No social media links detected.
  8. No explicit security policy or incident response information published.
  9. Domain DNSSEC not enabled, which is a minor security gap.
  10. Use of multiple third-party scripts for analytics and accessibility.
Technical notes

Notes

The website is built on a modern front-end stack using Bootstrap for responsive design, jQuery for DOM manipulation, and Google Tag Manager for analytics. Accessibility is enhanced via ACSB accessibility scripts. The site uses OneTrust for cookie consent management, indicating compliance with privacy regulations. Hosting is provided by GoDaddy, a reputable registrar and hosting provider. Performance is moderate, with multiple external resources loaded, including fonts and icon libraries. The site is mobile-optimized and includes accessibility features, but SEO could be improved with additional meta tags and structured data. No CMS was detected, suggesting a custom or static site architecture. Overall, the technical infrastructure supports the business goals but could benefit from performance tuning and enhanced security configurations.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with amicusassisthcp.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review amicusassisthcp.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.